Related Experiment Video
Updated: Jul 8, 2025
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
28.6K
Treatment-Resistant Juvenile Depression-A Quicksand?
Ahmed Naguy1, Saxby Pridmore2, Hessa Alhazeem3
1Naguy, MBBch, MSc, Al-Manara CAP Centre, Kuwait Centre for Mental Health (KCMH), Shuwaikh, State of Kuwait.
Psychopharmacology Bulletin
|December 11, 2023
Summary
Research on treatment-resistant juvenile depression is limited, highlighting a need for more studies. Effective treatment strategies for adolescents with persistent depression require further investigation to guide clinical practice.
Area of Science:
- Child and Adolescent Psychiatry
- Mental Health Research
- Clinical Psychology
Background:
- Juvenile depression research is advancing.
- Evidence for effective treatments for treatment-resistant juvenile depression is limited.
- Clinicians need guidance for managing complex pediatric depression cases.
Purpose of the Study:
- To address the limited evidence base for treatment-resistant juvenile depression.
- To identify effective therapeutic strategies for adolescents with persistent depression.
- To provide guidance for clinicians facing challenging cases of juvenile depression.
Main Methods:
- Literature review on existing treatment modalities.
- Analysis of current research gaps in pediatric depression.
- Synthesis of clinical case studies (if applicable).
Main Results:
- Significant limitations in evidence-based treatments for treatment-resistant juvenile depression identified.
- Key areas for future research in adolescent depression highlighted.
- Clinical challenges in managing persistent juvenile depression underscored.
Conclusions:
- There is a critical need for more research into effective treatments for treatment-resistant juvenile depression.
- Further studies are essential to guide clinical decision-making in pediatric mental health.
- Advancing the understanding of juvenile depression treatments is crucial for improving patient outcomes.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
247
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
247
01:30Electroconvulsive Therapy
41
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
41
01:24Treatment Strategies for Psychological Disorders
137
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
137
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
400
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
400
01:18Depression: Overview
251
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
251
01:24Mania and Antimanic Drugs: Overview
193
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
193